Inhibition of angiotensin II-induced contraction by losartan in human coronary arteries

Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

Bibtex

@article{8dba5fe5f18d4c8f857b145d7d297fbf,
title = "Inhibition of angiotensin II-induced contraction by losartan in human coronary arteries",
abstract = "The in vitro effects of angiotensin II (Ang II) in human vessels are not well studied. The development of specific Ang II-receptor antagonists has made it possible to delineate more carefully the receptor mechanisms involved. The objective of this study was twofold: to investigate the effect of Ang II on human coronary arteries and to study the effects of angiotensin II type 1 receptor blockade with losartan. The setting was contractile experiments with ring segments of coronary arteries. We observed that Ang II is a vasoconstrictor of human coronary arteries, with a pEC50 value of 9.26 +/- 0.22 and Emax of 68.7 +/- 9.61% of potassium-induced contraction. Losartan (10-100 nM) shifted the concentration-response curve of Ang II to the right, with pEC50 values of 7.64 +/- 0.10 and 7.00 +/- 0.15, respectively (p = 0.001), demonstrating the antagonistic properties of losartan. We also noted a decreased maximal response to Ang II after incubation of losartan, with Emax of 51.1 +/- 7.08% and 41.9 +/- 4.70% (p = 0.05), respectively. In conclusion, this is the first report describing the contractile effect of Ang II and the antagonizing effects of losartan in isolated human coronary arteries.",
author = "Anton Holmgren and Emil Pantev and David Erlinge and Lars Edvinsson",
year = "1998",
language = "English",
volume = "32",
pages = "662--664",
journal = "Journal of Cardiovascular Pharmacology",
issn = "1533-4023",
publisher = "Lippincott Williams & Wilkins",
number = "4",

}